US Stock MarketDetailed Quotes

MDGL Madrigal Pharmaceuticals

Watchlist
  • 229.840
  • +13.790+6.38%
Close May 3 16:00 ET
  • 231.000
  • +1.160+0.50%
Post 18:51 ET
4.89BMarket Cap-11497P/E (TTM)

About Madrigal Pharmaceuticals Company

Madrigal Pharmaceuticals, Inc. engages on the development and commercialization of innovative therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product, MGL-3196, is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. The company was founded by Rebecca Taub and Edward Chiang on September 2011 and is headquartered in Fort Washington, PA.

Company Profile

SymbolMDGL
Company NameMadrigal Pharmaceuticals
Listing DateFeb 6, 2007
Issue Price12.01
Founded2011
CEOMr. William John (Bill) Sibold
MarketNASDAQ
Employees276
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address200 Barr Harbor Drive,Suite 200
CityWest Conshohocken
ProvincePennsylvania
CountryUnited States of America
Zip Code19428
Phone1-267-824-2827
Websitehttp://www.madrigalpharma.com

Company Executives

  • Name
  • Position
  • Salary
  • William John (Bill) Sibold
  • Director, President and Chief Executive Officer
  • 32.27M
  • Dr. Robert E. Waltermire, PhD
  • Chief Pharmaceutical Development Officer
  • --
  • Dr. Rebecca A. Taub,M.D.
  • Director, Chief Medical Officer and President, Research and Development
  • 6.93M
  • Carole Huntsman
  • Chief Commercial Officer
  • 3.14M
  • Mardi C. Dier
  • Senior Vice President, Chief Financial Officer and Principal Accounting Officer
  • --
  • Brian Joseph Lynch
  • Senior Vice President and General Counsel
  • 5.27M
  • Julian C. Baker
  • Chairman of the Board
  • 646.00K
  • Dr. Paul A. Friedman,M.D.
  • Director
  • 9.56M
  • Kenneth M. Bate
  • Independent Director
  • 383.63K
  • James M. Daly
  • Independent Director
  • 363.63K
  • Dr. Frederick B. Craves, PhD
  • Lead Independent Director
  • 371.13K
  • Raymond Cheong, M.D.,PhD
  • Independent Director
  • 639.75K
  • Dr. Richard S. Levy,M.D.
  • Independent Director
  • 368.63K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg